Literature DB >> 11157839

Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. European IVF-Monitoring Programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE).

K G Nygren1, A N Andersen.   

Abstract

European results of assisted reproductive techniques from treatments initiated during 1997 are presented in this first ESHRE report. Data were collected from 18 European countries, usually from already-existing national registers. A total of 482 clinics from these 18 countries reported 203 893 cycles. In 10 countries with complete registration, 133215 cycles were performed in a population of 174 million, corresponding to 765 cycles per million inhabitants. After IVF and intracytoplasmic sperm injection (ICSI), the distribution of transfer of one, two, three and four or more embryos was 11.5, 35.9, 38.4 and 14.3% respectively. Huge differences existed between countries. For IVF, the clinical pregnancy rate per transfer was 26.1%, and the delivery rate per embryo transfer 20.9%. For ICSI, the corresponding rates were 26.4% and 21.5%. Singleton, twin, triplet and quadruplet delivery rates for IVF were 70.4, 25.8, 3.6 and 0.2% respectively, giving a total multiple delivery rate for IVF of 29.6%. After ICSI, the corresponding rates were 71.7, 25.2, 2.9 and 0.1%, amounting to a total multiple delivery rate of 28.2%. The range of triplet delivery rates after IVF range from 0.4% to 11.9% among countries.

Entities:  

Mesh:

Year:  2001        PMID: 11157839     DOI: 10.1093/humrep/16.2.384

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  16 in total

Review 1.  Protein supplementation of human IVF culture media.

Authors:  Deborah Blake; Peter Svalander; Meishan Jin; Christer Silversand; Lars Hamberger
Journal:  J Assist Reprod Genet       Date:  2002-03       Impact factor: 3.412

Review 2.  Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies.

Authors:  Frans M Helmerhorst; Denise A M Perquin; Diane Donker; Marc J N C Keirse
Journal:  BMJ       Date:  2004-01-23

3.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

Review 4.  Public financing of IVF: a review of policy rationales.

Authors:  Philipa Mladovsky; Corinna Sorenson
Journal:  Health Care Anal       Date:  2009-04-03

5.  Women's health and Chinese integrative medicine.

Authors:  Fan Qu; Fang-Fang Wang; Nicola Robinson; Paul J Hardiman
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

6.  Association of controlled ovarian hyperstimulation treatment with down-regulation of key regulators involved in embryonic implantation in mice.

Authors:  Min Xiong; Hanwang Zhang; Lei Jin; Jihui Ai; Zhiyong Huang; Guijin Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

7.  Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE.

Authors:  J de Mouzon; V Goossens; S Bhattacharya; J A Castilla; A P Ferraretti; V Korsak; M Kupka; K G Nygren; A Nyboe Andersen
Journal:  Hum Reprod       Date:  2012-02-17       Impact factor: 6.918

8.  Monitoring of IVF birth outcomes in Finland: a data quality study.

Authors:  Mika Gissler; Reija Klemetti; Tiina Sevón; Elina Hemminki
Journal:  BMC Med Inform Decis Mak       Date:  2004-03-10       Impact factor: 2.796

9.  Demographic relevancy of increased use of assisted reproduction in European countries.

Authors:  Jirina Kocourkova; Boris Burcin; Tomas Kucera
Journal:  Reprod Health       Date:  2014-05-26       Impact factor: 3.223

10.  The demographics of assisted reproductive technology births in a Nordic country.

Authors:  Alice Goisis; Siri Eldevik Håberg; Hans Ivar Hanevik; Maria Christine Magnus; Øystein Kravdal
Journal:  Hum Reprod       Date:  2020-06-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.